Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPAGLIFLOZIN Cause Myocardial infarction? 664 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 664 reports of Myocardial infarction have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 3.1% of all adverse event reports for DAPAGLIFLOZIN.

664
Reports of Myocardial infarction with DAPAGLIFLOZIN
3.1%
of all DAPAGLIFLOZIN reports
54
Deaths
221
Hospitalizations

How Dangerous Is Myocardial infarction From DAPAGLIFLOZIN?

Of the 664 reports, 54 (8.1%) resulted in death, 221 (33.3%) required hospitalization, and 129 (19.4%) were considered life-threatening.

Is Myocardial infarction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 664 reports have been filed with the FAERS database.

What Other Side Effects Does DAPAGLIFLOZIN Cause?

Death (2,775) Diabetic ketoacidosis (1,773) Acute kidney injury (982) Off label use (891) Nausea (884) Dehydration (860) Vomiting (838) Dizziness (817) Ketoacidosis (803) Fatigue (785)

What Other Drugs Cause Myocardial infarction?

ROSIGLITAZONE (17,018) TESTOSTERONE (3,396) ADALIMUMAB (3,214) SACUBITRIL\VALSARTAN (3,120) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,391) APIXABAN (2,010) TICAGRELOR (1,749) LENALIDOMIDE (1,712) ETANERCEPT (1,693) METFORMIN\ROSIGLITAZONE (1,640)

Which DAPAGLIFLOZIN Alternatives Have Lower Myocardial infarction Risk?

DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN DAPAGLIFLOZIN vs DAPRODUSTAT DAPAGLIFLOZIN vs DAPSONE DAPAGLIFLOZIN vs DAPTOMYCIN

Related Pages

DAPAGLIFLOZIN Full Profile All Myocardial infarction Reports All Drugs Causing Myocardial infarction DAPAGLIFLOZIN Demographics